Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.41B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 6.79M
Average 5.33M
ALHC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Alignment Healthcare, Inc.NASDAQ: ALHC
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables declines year over year
Q1 FY2026 accounts receivables of $24.47M (cash outflow) fell 59.3% year over year, behind the -37.4% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +42.8% a year.
Context
- Accounts receivables amounted to 2.5% of revenue in FY2025, up 1.3 pp from a year earlier.
- Accounts receivables grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -59.3% toward the trailing-twelve-month pace of -37.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (100.11M) USD
- Year-over-year change
- -192.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (100.11M) | -192.0% |
| FY2024 | 2024-12-31 | (34.28M) | -27.2% |
| FY2023 | 2023-12-31 | (26.95M) | +21.6% |
| FY2022 | 2022-12-31 | (34.38M) | -95.2% |
| FY2021 | 2021-12-31 | (17.61M) | — |
Accounts Receivables vs competitors
How ALHC compares with its peers on the latest reported figures
- ALHC's LTM Mar 2026 accounts receivables of $30.77M is the smallest of the 7 companies compared; the peer median is $102.5M.
- Its year-over-year change of -37.4% is the 3rd highest of 7, against a peer median of -71.3%.
- Accounts receivables amounts to 0.7% of revenue for ALHC, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.54B | -69.6% | — | 0.8% | |
| LTM Sep 2026 | $373M | +326.1% | +15.1% | 0.9% | |
| LTM Sep 2026 | $147M | -73.0% | +119.4% | 0.1% | |
| LTM Sep 2026 | $140M | -96.0% | +0.2% | 0.1% | |
| LTM Jun 2026 | $81.93M | +512.9% | — | 0.5% | |
| LTM Sep 2026 | $65M | -96.8% | — | 0.0% | |
| LTM Mar 2026 | $30.77M | -37.4% | +42.8% | 0.7% | |
| Peer median (excluding ALHC) | $102.5M | -71.3% | +15.1% | 0.3% | |
Competitors are the stored peer set for ALHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (195.29M) | (149.64M) | (148.17M) | (128.07M) | (724K) |
| Depreciation & Amortization | 16.03M | 17.49M | 21.67M | 27.06M | 31.61M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 110.6M | 81.72M | 66.84M | 71.13M | 62.08M |
| Change in Working Capital | (19.42M) | (5.55M) | 2.03M | 60.89M | 35.14M |
| Accounts Receivables | (17.61M) | (34.38M) | (26.95M) | (34.28M) | (100.11M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 437K | 13.74M | (6.35M) | (1.46M) | 0 |
| Other Working Capital | (2.25M) | 15.08M | 35.32M | 96.63M | 135.25M |
| Other Non-Cash Items | 9.29M | 10.56M | (1.54M) | 3.76M | 11.82M |
| Operating Cash Flow | (78.78M) | (45.43M) | (59.19M) | 34.77M | 139.93M |
| Capital Expenditures | (18.36M) | (23.77M) | (36M) | (41.42M) | (26.78M) |
| Acquisitions (Net) | 0 | (4.04M) | 0 | 0 | 1.14M |
| Purchases of Investments | (2.48M) | (2.83M) | (379.06M) | (82.2M) | (65.63M) |
| Sales of Investments | 1.43M | 2.43M | 267.79M | 162.8M | 76.3M |
| Other Investing Activities | (1.41M) | 0 | 0 | 14K | 0 |
| Investing Cash Flow | (20.82M) | (28.22M) | (147.26M) | 39.19M | (14.97M) |
| Debt Repayment | 0 | 21.82M | 0 | 165M | 0 |
| Common Stock Issued | 390.6M | 0 | 0 | 0 | 18.07M |
| Common Stock Repurchased | (1.47M) | 0 | 0 | (350K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (29M) | (5.23M) | 105K | (8.62M) | (26K) |
| Financing Cash Flow | 360.13M | 16.59M | 105K | 156.03M | 18.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 260.54M | (57.05M) | (206.35M) | 229.99M | 142.99M |
| Free Cash Flow | (97.14M) | (69.2M) | (95.18M) | (6.65M) | 113.15M |
Alignment Healthcare, Inc.
NASDAQ:ALHC
Intrinsic Alpha fair value
Locked
Current Price
$6.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.